who should not take glp-1 receptor agonists and Research to Treat Overeating and Substance Use Disorders Glucagon-Like Peptide-1 Receptor Agonists in
Description
10.1016/j.diabres.2012.09.008 [DOI] [PubMed] [Google Scholar] 210.Wenjing H, Shao Y, Yu Y, Huang W, Feng G, Li J
The cardiovascular benefits of GLP-1RAs extend beyond their effects on blood glucose levels
The hormone also suppresses glucagon, preventing the liver from releasing additional glucose into the bloodstream
The role of GIP in the regulation of GLP-1 satiety and nausea
Mekala A, Qiu H
doi: 10.3233/JAD-191068 [DOI] [PubMed] [Google Scholar] 9
